Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Bhoo Pathy, Nirmala ^a,b,c   Peeters, Petra ^a,d   Uiterwaal, Cuno ^a   Bueno de Mesquita, H Bas ^a,b,d,e   Bulgiba, Awang M ^b   Bech, Hammer ^f   Overvad, Kim ^f   Tjønneland, Anne ^g   Olsen, Anja ^g   Clavel Chapelon, Françoise ^h,i   Fagherazzi, Guy ^h,i   Perquier, Florence ^h,i   Teucher, Birgit ^j   Kaaks, Rudolf ^j   Schütze, Madlen ^k   Boeing, Heiner ^k   Lagiou, Pagona ^l   Orfanos, Philippos ^l   Trichopoulou, Antonia ^l,m   Agnoli, Claudia ⁿ   Mattiello, Amalia ^o   Palli, Domenico ^p   Tumino, Rosario ^q   Sacerdote, Carlotta ^r   Van Duijnhoven, Franzel ^e,s   Braaten, Tonje ^t   Lund, Eiliv ^t   Skeie, Guri ^t   Redondo, María Luisa ^u   Buckland, Genevieve ^v   Pérez, Sánchez ^w,x   Chirlaque, Maria Dolores ^x,y   Ardanaz, Eva ^x,z   Amiano, Pilar ^x,aa   Wirfält, Elisabet ^ab   Wallström, Peter ^ab   Johansson, Ingegerd ^ac   Nilsson, Maria ^ac   Khaw, Kay Tee ^ad   Wareham, Nick ^ae   Allen, Naomi E ^af   Key, Timothy J ^af   Rinaldi, Sabina ^ag   Romieu, Isabelle ^ag   Gallo, Valentina ^d,ah   Riboli, Elio ^d   Van Gils, Carla H ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f AARHUS UNIVERSITY   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m HELLENIC HEALTH FOUNDATION   (Greece)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r HuGeF Foundation and CPO Piemonte   (Italy)

^s WAGENINGEN UNIVERSITY   (Netherlands)

^t UNIVERSITY OF TROMSØ   (Norway)

^u Health and Health Care Services Council   (Spain)

^v CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^z INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aa Public Health Division of Gipuzkoa Instituto Investigación Sanitaria   (Spain)

^ab LUND UNIVERSITY   (Sweden)

^ac UMEÅ UNIVERSITY   (Sweden)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae MEDICAL RESEARCH COUNCIL   (United Kingdom)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ah QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; COFFEE; TEA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK REDUCTION; TEA; BREAST NEOPLASMS; COHORT ANALYSIS; EUROPE; MENOPAUSE; METABOLISM; MIDDLE AGED; REGISTER; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; COFFEE; COHORT STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TEA;

EID: 84924263203     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0521-3     Document Type: Article

References (43)

1. Holick CN, Smith SG, Giovannucci E, Michaud DS. Coffee, tea, caffeine intake and risk of adult glioma in 3 prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2010;19:39-47.
2. Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Lett. 2009;277:121-5.
3. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9:429-39.
4. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002;40:1155-63.
5. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer. 2009;115:2765-74.
6. Jernström H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis. 2003;24:991-1005.
7. Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, et al. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer. 2010;17:125-34.
8. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005;12:1071-82.
9. Walker K, Bratton DJ, Frost C. Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer. 2011;105:1451-7.
10. Rice S, Whitehead SA. Phytoestrogens and breast cancer -promoters or protectors? Endocr Relat Cancer. 2006;13:995-1015.
11. World Cancer Research Fund. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
12. Jiang W, Yu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol. 2013;129:620-9.
13. Decaffeination. International Coffee Organisation, London. http://www.ico.org/Decaffeination.asp. Accessed 9 Sep 2014.
14. Clavel-Chapelon F, EBM-EPIC Group. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer. 2002;86:723-7.
15. Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, et al. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68:211-7.
16. Cho E, Chen WY, Hunter DJ, Stampfer MF, Colditz GA, Hankinson SE, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med. 2006;166:2253-9.
17. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106. doi: 10.1093/jnci/dju165.
18. Yu Y, Zhang D, Kang S. Black tea, green tea and risk of breast cancer: an update. Springerplus. 2013;2:240.
19. Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A. High coffee intake, but not caffeine, is associated with estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. Nutr Cancer. 2013;65:398-409.
20. Bhoo-Pathy N, Peeters P, van Gils C, Beulens JW, van der Graaf Y, Bueno-de-Mesquita B, et al. Coffee and tea intake and risk of breast cancer. Breast Cancer Res Treat. 2010;121:461-7.
21. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113-24.
22. Margetts BM, Pietinen P. European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. Int J Epidemiol. 1997;26:S1-5.
23. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6:407-13.
24. Slimani N, Kaaks R, Ferrari P, Casagrande C, Clavel-Chapelon F, Lotze G, et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr. 2002;5:1125-45.
25. Ferrari P, Day NE, Boshuizen HC, Roddam A, Hoffmann K, Thiébaut A, et al. The evaluation of the diet/disease relation in the EPIC study: considerations for the calibration and the disease models. Int J Epidemiol. 2008;37:368-78.
26. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524-32.
27. Vatten LJ, Solvoll K, Loken EB. Coffee consumption and the risk of breast cancer. A prospective study of 14, 593 Norwegian women. Br J Cancer. 1990;62:267-70.
28. Tang N, Zhou B, Wang B, Yu R. Coffee consumption and risk of breast cancer: a meta-analysis. Am J Obstet Gynecol. 2009;200:290. e1-9.
29. Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, et al. Coffee consumption modifies risk of estrogen receptor negative breast cancer. Breast Cancer Res. 2011;13:R49.
30. Larsson SC, Bergkvist L, Wolk A. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes Control. 2009;20:2039-44.
31. Gierarch GL, Freedman ND, Andaya A, Hollenbeck AR, Park Y, Schatzkin A, et al. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer. 2012;131:452-60.
32. Fagherazzi G, Touillaud MS, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I. No association between coffee, tea, or caffeine consumption and breast cancer risk in a prospective cohort study. Public Health Nutr. 2011;14:1315-20.
33. Boggs DA, Palmer JR, Stampfer MJ, Spiegelman D, Adams-Campbell LL, Rosenberg L. Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study. Cancer Causes Control. 2010;21:1941-8.
34. Ishitani K, Lin J, Manson JE, Buring JE, Zhang SM. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med. 2008;168:2022-31.
35. Ganmaa D, Willet WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer. 2008;122:2071-6.
36. Michels KB, Holmberg L, Bergkvist L, Wolk A. Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish Women. Ann Epidemiol. 2002;12:21-6.
37. Shlonsky AK, Klatsky AL, Armstrong MA. Traits of persons who drink decaffeinated coffee. Annals Epidemiol. 2003;13:273-9.
38. Leviton A, Allred EN. Correlates of decaffeinated coffee. Epidemiology. 1994;5:537-40.
39. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006;27:1310-5.
40. Nilsson LM, Wennberg M, Lindahl B, Elliason M, Jansson JH, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of first acute myocardial infarction; a nested case study. Nutr Metab Cardiovasc Dis. 2009;20:527-35.
41. Hildebrand JS, Patel AV, McCullough ML, Gaudet MM, Chen AY, Hayes RB, et al. Coffee, tea, and fatal oral/ pharyngeal cancer in a large prospective US cohort. Am J Epidemiol. 2013;177:50-8.
42. Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 2010;21:1533-44.
43. Heckman MA, Weil J. Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75:R77-87.